Global Patent Index - EP 2507260 A1

EP 2507260 A1 20121010 - OFA/ILRP DERIVED MODIFIED PEPTIDE

Title (en)

OFA/ILRP DERIVED MODIFIED PEPTIDE

Title (de)

OFA/ILRP-ABGELEITETES MODIFIZIERTES PEPTID

Title (fr)

PEPTIDE MODIFIÉ DÉRIVÉ À OFA/ILRP

Publication

EP 2507260 A1 20121010 (EN)

Application

EP 10785044 A 20101126

Priority

  • EP 09014931 A 20091202
  • EP 2010068280 W 20101126
  • EP 10785044 A 20101126

Abstract (en)

[origin: EP2330122A1] The present invention relates to a novel modified human oncofoetal antigen immature laminin receptor (OFA/iLR) ۥ derived peptide comprising the sequence VLIENPADV and its use for diagnostic and therapeutic purposes, specifically in cancer.

IPC 8 full level

C07K 14/47 (2006.01)

CPC (source: EP)

C07K 14/47 (2013.01)

Citation (search report)

See references of WO 2011067175A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

EP 2330122 A1 20110608; EP 2507260 A1 20121010; WO 2011067175 A1 20110609

DOCDB simple family (application)

EP 09014931 A 20091202; EP 10785044 A 20101126; EP 2010068280 W 20101126